Trade NKTR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Nektar Therapeutics (NKTR) is trading at US$41.17, up 0.91% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$2.53B. Over the past 52 weeks, NKTR has traded between US$33.40 and US$109.00. On Syfe you can trade NKTR with $0 commission and add it to your watchlist.
| Previous close | US$40.80 |
|---|---|
| Market cap | US$2.53B |
| 52-week range | US$33.40 – US$109.00 |
| Volume | 1.09M |
| Exchange | US |
Nektar Therapeutics
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.
Year: 1994
Nektar Therapeutics (NKTR) stock is trading at US$41.17, +0.91% from the previous close of US$40.80.
The market cap for Nektar Therapeutics (NKTR) stock is approximately US$2.53B.
The 52-week high for Nektar Therapeutics (NKTR) stock is US$109.00.
The 52-week low for Nektar Therapeutics (NKTR) stock is US$33.40.
Nektar Therapeutics (NKTR) does not currently pay a dividend.
Stay on top of NKTR
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
